ストックスクリーナーアプリを入手
4.27
0.47%
0.02
アフターアワーズ：
4.33
0.06
+1.41%
Unicycive Therapeutics Inc (UNCY) 最新ニュース
Custom watchlist performance reports with Unicycive Therapeutics Inc.Market Movement Recap & Risk Controlled Swing Trade Alerts - Newser
Will Unicycive Therapeutics Inc. stock recover after recent drop2025 Breakouts & Breakdowns & Free Reliable Trade Execution Plans - Newser
Shareholders SueWallSt in New Class Action Against Unicycive Therapeutics, Inc.Act Now - Seeking Alpha
How to track smart money flows in Unicycive Therapeutics Inc.Weekly Profit Analysis & Free High Accuracy Swing Entry Alerts - Newser
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics - PR Newswire
What the charts say about Unicycive Therapeutics Inc. todayDollar Strength & Long-Term Growth Portfolio Plans - Newser
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Urged to Join Class Action Before October 14, 2025Contact Levi & Korsinsky - ACCESS Newswire
UNCY Investors with Large Losses Should Contact Robbins LLP - GlobeNewswire
UNCY Investors with Large Losses Should Contact Robbins LLP for Information About Leading the Unicycive Therapeutics, Inc. Class Action - GlobeNewswire Inc.
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Unicycive Therapeutics, Inc. (UNCY) Investors of October 14, 2025 Deadline - ACCESS Newswire
Kaplan Fox Alerts Unicycive Therapeutics, Inc. (UNCY) Investors to a Securities Class Action LawsuitDeadline is October 14, 2025 | FinancialContent - FinancialContent
What earnings revisions data tells us about Unicycive Therapeutics Inc.Analyst Downgrade & Consistent Return Strategy Ideas - Newser
Securities Lawsuit Alert: Unicycive Therapeutics, Inc. (UNCY)Contact Levi & Korsinsky Before October 14, 2025 - ACCESS Newswire
Shareholders that lost money on Unicycive Therapeutics, Inc.(UNCY) Urged to Join Class ActionContact The Gross Law Firm to Learn More - PR Newswire
Unicycive Therapeutics to Participate in Upcoming Investor Events in September - GlobeNewswire
Kidney Disease Biotech Unicycive Therapeutics Sets Two Major Investor Conference Appearances in September - Stock Titan
Combining machine learning predictions for Unicycive Therapeutics Inc.2025 Valuation Update & Accurate Entry and Exit Point Alerts - Newser
Using data tools to time your Unicycive Therapeutics Inc. exitWeekly Risk Summary & Long-Term Capital Growth Ideas - Newser
Retail Surge: Can Unicycive Therapeutics Inc. weather a recessionBull Run & Daily Chart Pattern Signal Reports - sundaytimes.kr
Levi & Korsinsky Moves to SueWallSt for Unicycive Therapeutics, Inc. Investors That Lost Money - Stockhouse
Unicycive Therapeutics Class Action Lawsuit Filed Against Company and Officers. - AInvest
UNCY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Unicycive Therapeutics (NASDAQ:UNCY) Downgraded by Wall Street Zen to “Sell” - Defense World
Unicycive Therapeutics under investigation for potential securities fraud. - AInvest
Shareholders who lost money in shares of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Should Contact Wolf Haldenstein Immediately. - Barchart.com
Unicycive Therapeutics Raises $16.3 Million in Stock Sale - MSN
UNCY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Unicycive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Morningstar
Shareholders who lost money in shares of Unicycive - GlobeNewswire
Investors SueWallSt as Unicycive Therapeutics, Inc. Faces Securities Fraud Allegations - Nasdaq
Kaplan Fox Alerts Investors of Unicycive Therapeutics, Inc. (UNCY) to a Securities Class Action Deadline on October 14, 2025 - FinancialContent
Analyzing drawdowns of Unicycive Therapeutics Inc. with statistical tools2025 Valuation Update & Trade Opportunity Analysis Reports - Newser
Can Unicycive Therapeutics Inc. rally from current levelsJuly 2025 Selloffs & Weekly High Return Stock Forecasts - Newser
Using Python tools to backtest Unicycive Therapeutics Inc. strategiesJuly 2025 Recap & Accurate Buy Signal Notifications - Newser
Will Unicycive Therapeutics Inc. continue its uptrend2025 Technical Patterns & Smart Investment Allocation Insights - Newser
Why Unicycive Therapeutics Inc. is moving todayJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - Newser
Volume spikes in Unicycive Therapeutics Inc. stock – what they mean2025 Market Sentiment & Consistent Growth Equity Picks - Newser
Heatmap analysis for Unicycive Therapeutics Inc. and competitorsMarket Trend Report & Intraday High Probability Setup Alerts - Newser
Has Unicycive Therapeutics Inc. found a price floorJuly 2025 News Drivers & Daily Technical Forecast Reports - Newser
Shareholders of Unicycive Therapeutics, Inc. (UNCY): Protect Your Rights Before October 14, 2025Contact Levi & Korsinsky - ACCESS Newswire
SueWallSt With Us: Levi & Korsinsky Notifies Shareholders of Class Action Against Unicycive Therapeutics, Inc - ACCESS Newswire
Unicycive Therapeutics, Inc. (UNCY) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of October 14, 2025 Deadline - ACCESS Newswire
Unicycive Faces Class Action Over FDA Misleading Claims - TipRanks
UNCY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Unicycive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Will Unicycive Therapeutics Inc. bounce back from current supportJuly 2025 Macro Moves & Weekly High Return Stock Forecasts - Newser
How hedge fund analytics apply to Unicycive Therapeutics Inc. stockBuy Signal & Breakout Confirmation Trade Signals - Newser
0.98%
8.06%
大文字化:
|
ボリューム (24 時間):